Skip to content

SANUWAVE Health, Inc. SNWV Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

IRA
Iris Acquisition IRAB
$10.61M
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$297K+119%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$65.65K+260%
TRV
Trevi Therapeutics, Inc.TRVI
$0
Rumble, Inc. logo
Rumble, Inc.RUM
$29.43M+32,132%
Diversified Energy
 logo
Diversified Energy DEC
$6M

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: SANUWAVE Health, Inc.’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s payments of stock issuance costs?
SANUWAVE Health, Inc. (SNWV) reported payments of stock issuance costs of $100K in Q4 2024.
What does payments of stock issuance costs mean?
Cash outflows directly attributable to the issuance of equity securities, such as underwriting fees, legal costs, and registration expenses. These costs are typically deducted from the proceeds of the equity offering.